//////
AGENDA
Virtual media briefing
18:00 - 19:30 CEST
12:00 - 13:30 EST
Thursday, September 10, 2020
| SESSION TITLE | SPEAKERS |
|---|---|
| Opening and welcome | Dr. Kirhan Ozgurdal, Global Medical Affairs Physician – Oncology, Bayer |
| Importance of improving survival in patients with unresectable HCC | Dr. Catherine Frenette, Scripps Green Hospital, USA |
| Changing treatment landscape and importance of systemic therapy sequencing | Prof. Peter Galle, University Medical Center Mainz, Germany |
| Effective treatment and management plan to improve survival in HCC | Dr. Richard Finn, UCLA Medical Center, USA |
| Facilitated Q&A | Dr. Catherine Frenette, Prof. Richard Finn, Prof. Peter Galle, Prof. Jean-Frédéric Blanc, Le Centre Hospitalier Universitaire de Bordeaux, France |
| Summary and close | Dr. Catherine Frenette |
| Opportunity for 1:1 interviews with panellists | Dr. Catherine Frenette and Dr. Richard Finn, USA Prof. Peter Galle, Germany, Prof. Jean-Frédéric Blanc, France |